Podcasts about patients

Guests: Captain James Fanell (USN Ret.) and Bradley Thayer. Fanell argues the U.S. must "admit failure" regarding China, likening the situation to a patient acknowledging cancer to begin treatment. To combat "threat deflation" and institutional bias in intelligence, they propose a "Team B" of independent analysts to objectively assess PRC capabilities. Thayer advocates moving oversight of foreign investment (CFIUS) to the Department of Defense and ultimately cutting off all trade to deny the CCP resources and protect intellectual property.

Police Addicted to Drugs And His Amazing Recovery, Special Episode. Police Officer Attacked, Multiple Surgeries, Forced Retirement, Addiction, and an Inspiring Recovery. This special episode is streaming for free on the Law Enforcement Talk Radio Show and Podcast website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform Brock Bevell never imagined that a single violent moment would change the entire trajectory of his life. A retired Mesa, Arizona police officer, Brock dedicated his career to public service, until a targeted act of violence ended his time on the job and set him on a painful, unexpected journey through addiction and recovery. Look for The Law Enforcement Talk Radio Show and Podcast on social media like their Facebook , Instagram , LinkedIn , Medium and other social media platforms. “She threw the truck into reverse and hit me,” Brock recalls. “In an instant, everything changed.” Supporting articles about this and much more from Law Enforcement Talk Radio Show and Podcast in platforms like Medium , Blogspot and Linkedin . A Career Cut Short by Violence While serving with the Mesa Police Department, Brock was seriously injured during a violent incident involving a vehicle. The attack caused devastating, career-ending injuries and required multiple surgeries. What followed was a long and grueling rehabilitation process, one familiar to many injured officers across the country. Police Addicted to Drugs And His Amazing Recovery, Special Episode. Available for free on their website and streaming on Apple Podcasts, Spotify, Youtube and other podcast platforms. To manage the intense pain, Brock was prescribed opioid pain medication. Like countless patients recovering from serious injuries, he trusted the prescriptions meant to help him heal. Instead, they quietly became the beginning of a much deeper struggle. From Recovery to Addiction During months of surgeries and physical therapy, Brock developed a severe dependence on opioid painkillers. What started as medically prescribed relief slowly evolved into addiction. “I didn't recognize myself anymore,” Brock says. “My world became smaller and darker. I was surviving, not living.” Brock openly shares how addiction affected every part of his life, his relationships, his identity, and his sense of purpose after forced retirement from policing. His story reflects a reality many first responders face but few openly discuss. Police Addicted to Drugs And His Amazing Recovery, Special Episode. The Law Enforcement Talk Radio Show and Podcast episode is available for free on their website , Apple Podcasts , Spotify and most major podcast platforms. The Science Behind the Crisis Research underscores just how common Brock's experience is. A major study published in JAMA Internal Medicine by researchers at the Stanford University School of Medicine found that patients undergoing 11 common surgeries faced an increased risk of becoming chronic opioid users. Lead author Eric Sun, MD, PhD, explained: “For a lot of surgeries, there is a higher chance of getting hooked on painkillers.” The study defined chronic opioid use as filling 10 or more prescriptions or receiving more than a 120-day supply within a year after surgery. Patients undergoing knee surgery faced the highest risk, nearly five times that of nonsurgical patients, followed by gallbladder surgery. Importantly, the study did not suggest avoiding surgery, but emphasized the need for careful monitoring and alternative pain management strategies. Police Addicted to Drugs And His Amazing Recovery, Special Episode. The interview can be found on The Law Enforcement Talk Radio Show and Podcast website, on Apple podcasts, Spotify, Youtube and on LinkedIn, Facebook, Instagram, and across most podcast platforms where listeners will find authentic law enforcement stories. Trauma, Policing, and Substance Use Law enforcement officers face unique occupational hazards, including repeated exposure to trauma. Studies show that substance use disorders, including alcohol and drug dependence, occur at higher rates among officers, particularly those experiencing psychological distress. In nationally representative data, more than half of men with lifetime PTSD also had a history of alcohol abuse or dependence. For police officers, these risks are compounded by work stress, injuries, and the cultural stigma surrounding mental health and asking for help. “We wear the uniform, but we're human,” Brock says. “And sometimes the damage doesn't show until it's almost too late.” The full podcast episode is streaming now on their website, on Apple Podcasts, Spotify, Youtube and across Facebook, Instagram, and LinkedIn. Hitting Bottom and Choosing Recovery Brock's turning point came when he realized addiction had taken everything it could from him. With professional help, support, and unwavering determination, he entered recovery and committed to sobriety. “Recovery didn't give me my old life back,” he says. “It gave me a new one, one with purpose.” Police Addicted to Drugs And His Amazing Recovery, Special Episode. Today, Brock uses his experience to help others struggling with addiction, trauma, and life after law enforcement. His message is clear: recovery is possible, even after profound loss. Healing Beyond the Badge In the aftermath of violence and trauma, communities often look to police officers as symbols of strength. Yet officers themselves must also heal. Proactive wellness programs, mental health resources, and open conversations about addiction are critical, not just for officers, but for the communities they serve. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Mesa, located just east of Phoenix, is known for its deep history, from the ancient Hohokam culture to the modern city Brock once patrolled. It is also where his story originated, one of resilience, accountability, and hope. Listen to Brock's Story Brock Bevell's journey is featured in this Special Episode of the Law Enforcement Talk Radio Show and Podcast available for free on their website, also on Platforms like Apple Podcasts, Spotify, YouTube and most major podcast platforms. His story is also being shared across their Facebook, Instagram, LinkedIn, and other Social Media and News outlets. Listen to Brock's inspiring account of what happened, how prescribed opioids led to addiction, and how recovery helped him rebuild his life, and helps others do the same. Police Addicted to Drugs And His Amazing Recovery, Special Episode. Because sometimes, the most powerful stories of policing aren't about arrests or badges, but about survival, healing, and redemption. You can help contribute money to make the Gunrunner Movie . The film that Hollywood won't touch. It is about a now Retired Police Officer that was shot 6 times while investigating Gunrunning. He died 3 times during Medical treatment and was resuscitated. You can join the fight by giving a monetary “gift” to help ensure the making of his film at agunrunnerfilm.com . Background song Hurricane is used with permission from the band Dark Horse Flyer. You can contact John J. “Jay” Wiley by email at Jay@letradio.com , or learn more about him on their website . Stay connected with updates and future episodes by following the show on Facebook, Instagram, LinkedIn, their website and other Social Media Platforms. Find a wide variety of great podcasts online at The Podcast Zone Facebook Page , look for the one with the bright green logo. Be sure to check out our website . Be sure to follow us on X , Instagram , Facebook, Pinterest, Linkedin and other social media platforms for the latest episodes and news. Listeners can tune in on the Law Enforcement Talk Radio Show website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform and follow updates on Facebook, Instagram, and other major News outlets. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Police Addicted to Drugs And His Amazing Recovery, Special Episode. Attributions Stanford Medical IACP NIH Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this special festive episode of “How Do You Say That?!” sponsored by britishvoiceover.co.uk, Katy Maw and Phil Rowe join Sam and Mark for a right-old Christmas knees-up. As it's Boxing Day - there are four boxes stuffed with seasonal audio goodies! Of course, there are also four scripts, full of festive goodness... and some wildcards too!This episode is also entirely on video - only the second one we've done this way, so you can watch it on YouTube as well: https://youtu.be/WVclGe-xKaEGet involved! Have you got a Wildcard suggestion that we should try or an idea for the show? Send it to us via Mark or Sam's social media or email it directly to podcast@britishvoiceover.co.ukScript 1Cassandra made a great start in secondary school this year. Better than we could have hoped for. Her number one sport continues to be water polo. She also joined the school concert band and jazz band. She has made a lot of friends and is popular in her year.Jacqui manages to train as a surgeon while fitting in diving trips to Thailand, Cayman, Cuba and the Red Sea. We've told you about Tori's sporting prowess, and at number 5 in the world, she is not doing badly! The boys have a hamster.Script 2It was snowing. It was always snowing at Christmas. December, in my memory, is white as Lapland, although there were no reindeers. But there were cats. Patient, cold and callous, our hands wrapped in socks, we waited to snowball the cats. Sleek and long as jaguars and horrible-whiskered, spitting and snarling, they would slide and sidle over the white back-garden walls, and the lynx-eyed hunters, Jim and I, fur-capped and moccasined trappers from Hudson Bay, off Mumbles Road, would hurl our deadly snowballs at the green of their eyes.Script 311 a.m. Office. Oh my God. Daniel Cleaver just sent me a message. Message Jones: You appear to have forgotten your skirt. As I think is made perfectly clear in your contract of employment, staff are expected to be fully dressed at all times. CleaveHah! Undeniably flirtatious. Have never messaged Daniel Cleaver before but brilliant thing about messaging system is you can be really quite cheeky and informal, even to your boss. Also can spend ages practising. This is what I sent:Script 4The finger pointed from the grave to him, and back again."No, Spirit! Oh no, no!"The finger still was there."Spirit!" he cried, tight clutching at its robe, "hear me!I am not the man I was. I will not be the man I must have been but for this intercourse. Why show me this, if I am past all hope!"For the first time the hand appeared to shake.We'd love your feedback - and if you listen on Apple Podcasts or Spotify, hit the follow button today!**Listen to all of our podcasts here - you can also watch on YouTube, or say to your smart speaker "Play How Do You Say That?!"About our guests: Katy Maw has been voicing for about a quarter of a century after becoming a classically trained actor in London. She works daily, predominantly on corporate & commercial scripts & has voiced literally thousands of local & National radio ads over the years and she works across all other mediums of voicing, like e-learning and...

Three children were killed in a house fire in Jackson County, Kentucky, over the holiday. Another child was taken to a hospital in Ohio. The death toll from last month's crash of a cargo jet in Louisville has risen. Patients with a rare form of A-L-S may finally have new hope...in some cases, reverse the symptoms. See omnystudio.com/listener for privacy information.

CardioNerds (Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Natalie Marrero) discuss anti-arrhythmic drugs in the management of atrial fibrillation and atrial flutter with electrophysiologist Dr. Andrew Epstein. We discuss two major classes of anti-arrhythmic drugs, class IC and class III, as well as digoxin. Dr. Epstein explains their mechanisms of action, indications and specific patient populations in which they would be particularly helpful, efficacy, adverse side effects, contraindications, and key drug-drug interactions. We also elaborate on defining clinical trials and their clinical implications. Given the large burden of atrial fibrillation and atrial flutter in our patient population and the high prevalence of anti-arrhythmic drug use, this episode is sure to be applicable to many practicing physicians and trainees. Audio editing by CardioNerds academy intern, Grace Qiu.  Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Anti-arrhythmic drugs should not be thought of as an alternative to ablation but, instead, should be considered an adjunct to catheter ablation.   Class IC anti-arrhythmic drugs, flecainide and propafenone, are highly efficacious for acute cardioversion and a great option for patients with infrequent episodes of AF who do not have a history of ischemic heart disease.    Class III anti-arrhythmic drugs like ibutilide, sotalol, and dofetilide, are highly effective for acute conversion; however, they require hospitalization for close monitoring during initiation and dose titration given the risk of prolonged QT.   Amiodarone should not be used as a first line agent given its toxicities, prolonged half-life, large volume of distribution, and drug-drug interactions.   Dr. Epstein notes that, “All drugs are poisons with a few beneficial side effects,” when highlighting the many adverse side effects of anti-arrhythmic drugs, particularly amiodarone, and the importance of balancing their benefit in rhythm control with their side effect profile.   Notes Notes: Notes drafted by Dr. Natalie Marrero. What are the Class IC anti-arrhythmic drugs and what indications exist for their use?   Class IC anti-arrhythmic drugs are anti-arrhythmic drugs that work by blocking sodium channels and, thereby, prolonging depolarizing.   Class IC anti-arrhythmic drugs include flecainide and propafenone.   Class IC anti-arrhythmic drugs are good agents to use in patients that have infrequent episodes of AF and do not want daily dosing as these agents can be used by patients when they feel palpitations and desire acute conversion back to sinus rhythm (“pill in the pocket” approach).    What are the adverse consequences and/or contraindications to using a class IC agent?  Class IC anti-arrhythmic agents are contraindicated in patients with a history of ischemic heart disease based on increased mortality associated with their use in these patients in the CAST trial.   Given the results of the CAST trial, providers should screen annually for ischemia via a functional stress test in patients on these drugs at risk for coronary disease.   These drugs can increase 1:1 conduction of atrial flutter and, therefore, require concomitant use of a beta blocker.   These agents are generally well-tolerated without any organ toxicities; however, they can precipitate heart failure in patients with cardiomyopathies, cause sinus node depression, and unmask genetic arrythmias such as a Brugada pattern.   What are the class III agents and what are indications for their use?   Class III agents are drugs that block the potassium channel, prolonging the QT, and include Ibutilide, Sotalol, and Dofetilide.    Class III agents can be considered in patients with or without a history of ischemic heart disease that desire effective acute chemical cardioversion and are willing to go to the hospital for close monitoring during dose initiation and titration.   Other specific circumstances in which one can use these agents, specifically Ibutilide, are in patients with recurrent atrial fibrillation and Wolf Parkinson White (due to slowed conduction via the accessory pathway).  What are the adverse consequences and/or contraindications to using a class III agent?  Ibutilide, Sotalol, and Dofetilide prolong the QT and increase the risk of torsade de pointes, which is why they require ECG monitoring in-patient during drug initiation and dose titration.    These agents are generally well-tolerated.   Sotalol should be avoided or used cautiously in patients with left ventricular dysfunction, while dofetilide can be used and has dose-response beneficial effects in patients with left ventricular dysfunction.   Both sotalol and dofetilide are renally cleared with specific creatinine clearance cutoffs (CrCl < 20 for dofetilide and CrCl

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

“We get a lot of inappropriate over-prescribing for almost everything,” says drug policy researcher and journalist Alan Cassels.Cassels is the co-author of “Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients.”For Cassels, it was one disease in particular—osteoporosis—that changed his entire view of medicine.Based on changing definitions of the disease, large swaths of Americans could suddenly be declared sick and in urgent need of drug treatment.They “medicalized normal aging of basically the entire female population. Overnight,” he says.In our interview, we discuss the influence of the pharmaceutical industry on overdiagnoses and prescriptions, and how the criteria for many diseases can be expanded arbitrarily.“When you look closely at the quality of prescribing, a lot of times, the decision-making is not really driven by evidence. It's driven mostly by … marketing, biases, influence from thought leaders, and influence from guidelines, medical guidelines themselves, which are often appallingly biased,” he says.Many doctors, Cassels says, know little about the adverse effects of the many drugs they prescribe to their patients.We also dive into the connection between psychiatric drug prescriptions and violence, how psychiatry labels normal behaviors as abnormal, and how exaggerated statistics are used to sell theories of disease and drug treatments.Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

In this game-changing podcast episode host Jesse Ewell interviews Dr. Jamie West, a chiropractor turned functional medicine practitioner. They discuss Jamie's journey into functional medicine, the resistance she faced in incorporating new methods, and the transformative results her patients have experienced through a new weight loss program. The conversation highlights the shift from one-on-one patient care to a scalable model, the importance of effective marketing, and the financial success that has followed. Jamie shares personal insights on her own health transformation and offers advice for other practitioners considering similar paths. Dr. Jamie West transitioned from chiropractic to functional medicine. Resistance to new methods often stems from lack of research. Peptides can significantly aid in healing and weight loss. Patients experience rapid improvements, such as reduced brain fog. The program allows for scalable patient care without sacrificing results. Effective marketing builds confidence and trust in practitioners. Perfect for entrepreneurs, small business owners, and anyone looking to scale their business through social media. Click the link below and learn how Jesse and his team can help you achieve similar transformative results. To find out more about the VIP weight loss system email me directly or reach out on socila media. Learn more about Jesse though the following links: VIP WEIGHT LOSS SYSTEM HBL Lifestyle Secrets Group on Facebook Personal Website HBL Website Instagram Email  

This is a re-release celebrating a decade of love and allyship on A Gay And A NonGay. This week we're throwing it back to May 2020... We've heard about 'expendable' populations before, but last time they meant gay people. 32 million people have died of AIDS related illnesses since the 1980s and in 2018, 770,000 people died worldwide because of the virus. The London Patient: A Cure For HIV? is the first episode in a brand new two-part series - funded by the Wellcome Trust and the British Podcast Awards Fund. Both episodes were recorded in accordance with government social distancing measures. On this episode, we look at the start of the epidemic, chat to AIDS activist Sir Nick Partridge OBE and head to Oxford to meet Professor John Frater who explains the science behind HIV. Trigger warning: Contains upsetting audio. Incredible advances in medicine now mean that if you are HIV+ and on effective treatment, you can't pass it on. Undetectable = Untransmittable. And in March 2019, it was revealed that a second person had been cured of HIV - The London Patient. What does the London Patient's story tell us about a cure for HIV? Plus in the age of Covid19, can the story of HIV and AIDS offer the world any hope? This episode is bought to you with thanks to the ⁠MTV Staying Alive Foundation⁠, the ⁠Terrence Higgins Trust⁠ and the ⁠National AIDS Trust⁠. Follow A Gay & A NonGay TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠gaynongay.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email Us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠us@gaynongay.com⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

This year's biggest patient access wins didn't come from trend decks or theoretical frameworks — they came from listening. In this episode, we share the patterns Infinx heard repeatedly across calls with our clients, and what those signals revealed about what actually moved the needle in patient access.

How Did H2O Innovation Build a Water Empire Through 18+ Acquisitions (M&A) and What Happens Now Under Private Equity?More #water insights? Get my free mapping of 267 water investors here: https://investors.dww.show

If your clients aren't rebooking consistently, it's not a motivation problem… it's a systems problem. In this episode, I'm sharing a replay of a live training I taught in partnership with GlossGenius, where I broke down the 3 pillars of transformational client loyalty. We dive into how to move clients from one off appointments into long-term commitments, restructuring your menu around outcomes, and building an automated retention engine that works behind the scenes. I also share the CARES consultation framework, how to design a multi-million dollar menu built around solutions instead of services, and how automation can become your partner in driving rebooking, renewals, and long-term loyalty. Get ready to stop chasing rebookings and start leading with systems that make loyalty inevitable.   HIGHLIGHTS The 3 pillars of transformational client loyalty. Why most consultations fail to create long-term commitment. The CARES framework that turns consults into annual plans. The sales psychology technique that increases plan and package buy-in. Automation is your partner in retention and rebooking.   RESOURCES + LINKS Sign up to get a 2-week FREE trial of GlossGenius HERE Try Ask Heather AI for 30 Days HERE Apply for The Med Spa Advantage HERE   FOLLOW Heather: @heatherterveen Website: heatherterveen.com

HOW MUCH DO DENTAL IMPLANTS COST!? Download the FREE Guide to Dental Implants Here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/3MK6x31Want to know if you may be eligible for Permanent Teeth in 24 Hours? Take the 60-Sec Quiz Here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/49oywwX▬▬▬▬▬▬▬▬ Contents of this video ▬▬▬▬▬▬▬▬▬▬Disclaimer: Nuvia Dental Implant Centers are locally owned and operated by licensed dental practitioners. These locally owned and operated practices are part of a professional network of dental implant centers operated by prosthodontists, oral surgeons, and restorative dentists. Each Nuvia Dental Implant Center has a business affiliation with Nuvia MSO, LLC, a Dental Support Organization that provides non-clinical support to each center.*Nuvia Dental Implant Centers are able to provide patients with a bridge made with an FDA approved permanent material, zirconia, in 24-hours. No temporary denture. Not all those who come in for a consultation are medically cleared to receive permanent zirconia teeth in 24-hours. Follow up appointments are required to confirm implant integration and make adjustments if necessary. Results may vary in individual cases. Patients represented in videos are actual NUVIA patient(s) and may have been compensated for their time in telling their story.*While soft foods immediately after surgery are generally approved by our clinical team, the local surgeon may give individual instruction on dental implant aftercare according to the specific circumstances applicable to each case.To hear patient's speech after prosthetic placement please search Nuvia Dental Implant Center on YouTube and watch patient stories. *Individual results may vary based on a number of factors.Copyright 2024. Nuvia Dental Implant Centers. All rights reserved.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Long-Term Survival in Liver Transplant Patients With Coronary Artery Disease: A Multi-Institutional Study.

Jason Gilley walked into adulthood with a fastball, a college roster spot, and a head of curls that deserved its own agent. Cancer crashed that party and took him on a tour of chemo chairs, pediatric wards, metal taste, numb legs, PTSD, and the kind of late night panic that rewires a kid before he even knows who he is.I sat with him in the studio and heard a story I know in my bones. He grew up fast. He learned how to stare down mortality at nineteen. He found anchors in baseball, therapy, and the strange friendships cancer hands you when it tears your plans apart. He owns the fear and the humor without slogans or shortcuts. Listeners will meet a young man who refuses to let cancer shrink his world. He fights for the life he wants. He names the truth without apology. He reminds us that survivorship stays messy and sacred at the same time. This conversation will stay with you.RELATED LINKS• Jason Gilley on IG• Athletek Baseball Podcast• EMDR information• Children's Healthcare of AtlantaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

 Sandra and Greg Mundis are the resilient couple behind the inspirational real-life account, “Patient Number One: Embracing Hope in Times of Despair.” Greg, a global leader as Executive Director of Assemblies of God World Mission, and Sandra, a gifted storyteller and founder of Europe's Children ministry, have spent decades impacting lives across 195 countries. Their new book chronicles Greg's harrowing journey as the first COVID-19 intubation patient at his hospital—given little chance to live—and Sandra's fierce faith-fueled advocacy, demonstrating the miraculous power of hope, family, and community in the darkest times. In this episode of Marketer of the Day, Sandra and Greg join Robert Plank to share their journey from devastation to hope. They candidly detail Greg's critical illness, the emotional and physical ordeal of prolonged hospitalization and rehabilitation, Sandra's steadfast persistence, and the profound role faith and global prayer played in recovery. The conversation highlights themes of family unity, the psychological toll of crisis, finding purpose beyond suffering, and the decision to turn their collective trauma into a published story of inspiration. Listeners will learn about the importance of documenting miracles, building a support network, and how adversity can lead to deeper connection and renewed mission. Quotes: “If it wasn't for Jesus, I wouldn't be sitting here talking to you.” “God's word was like my food... There's power in those words, and it truly brought me through.” “If I take him home, it's the best thing I can do for him... But if I leave him, I want to receive the glory.” Resources: Buy “Patient Number One” on Amazon. Learn more about how they turn challenges into opportunities for change on their website Follow  Sandra and Greg Mundis on Facebook

When we think of potentially dangerous and addictive drugs, most of us think about illegal substances like heroine or cocaine. And yet widely-prescribed drugs like Xanax, Ritalin, Adderall, and Vicodin are also addictive, but legal in the United States. Historian David Herzberg discusses the artificial distinction that has been created between addictive drugs and medicines — with the key difference being the class and race of the consumers who use them and the partial protections that one group receives and the other does not. (Encore presentation.) David Herzberg, White Market Drugs: Big Pharma and the Hidden History of Addiction in America University of Chicago Press, 2020 The post Good Patients, Bad Addicts appeared first on KPFA.

Is IVF the answer for recurrent pregnancy loss? Why would IVF with genetic testing of embryo be helpful for people that are 'getting' pregnant but can 'stay' pregnant?  In this educational episode, Dr. Lora Shahine explains the complex relationship between IVF, genetics, and recurrent pregnancy loss. She reviews the science behind why chromosomal imbalances are one of the most common causes of first-trimester miscarriage and discusses how preimplantation genetic testing for aneuploidy (PGT-A) may help select embryos with the highest chance of success for some patients. Through real patient examples and evidence-based guidance, this episode explores the nuances of testing, timing, emotional well-being, and the ethical and financial considerations that shape decision-making. Listeners will walk away informed, empowered, and reminded that no matter their fertility path, they are not alone. In this episode you'll hear: [2:03] Why consider IVF for recurrent pregnancy loss? [4:10] IVF process & genetic testing [11:02] Real world counseling & patient scenarios [16:12] Pros & cons of IVF for recurrent pregnancy loss [24:58] Key considerations for IVF [28:15] Patient examples and recommendations [31:12] Final thoughts Dr. Shahine's Weekly Newsletter on Fertility News and Recommendations Follow @drlorashahine Instagram | YouTube | Tiktok | Her Books

If you've ever looked at your schedule and thought, “We're slammed…so why is my bank account not moving?” — this episode is going to feel like oxygen. In this PPS 2025 recap conversation, Jerry Durham sits down with Nathan Shields, founder of the Private Practice Owners Club, to break down the real reasons clinics bleed profit — and why the solution isn't more new patients. Across this episode, Nathan pulls back the curtain on the cash-flow killers hiding inside most clinics: weak collections, underperforming billing systems, inconsistent documentation, and a front desk that's unsupported (not unskilled). He also explains why AI won't fix broken processes — and why owners who skip the fundamentals end up scaling their problems, not their profit. In this episode you'll learn:The four internal “leaks” that cost clinics $100K–$300K per year — and how to close them fast.Why chasing more new patients is the wrong move when your systems are broken.The exact numbers every owner must know (and what they actually mean).How to tighten front-desk operations so patients arrive, pay, and stay.Why underbilling — not overbilling — is silently draining your margins.How AI can support your systems… but can't save you from bad processes.What PPS 2025 revealed about the future of private practice — and what owners need to fix BEFORE adding tech, growth, or new services. What you'll walk away with:A Cash-Flow Leak Audit you can run in 30 minutes.A simple 4-phase roadmap to increase revenue without increasing visits.Clarity on the 3–5 KPIs that actually drive your business (and which ones don't matter).Scripts for improving front-desk collections and reducing cancellations.A new lens for evaluating tech, platforms, and AI — so you stop wasting money and start moving the needle.

Today, Dave Furfaro, Luke Hedrick, and Robert Wharton discuss the PREDMETH trial published in The New England Journal of Medicine in 2025. This was a non-inferiority trial comparing prednisone to methotrexate for upfront therapy in treatment-naive sarcoidosis patients. Listen in for a break down of the trial, analysis, and clinically applicable pearls. Article and Reference Todays’ episode discusses the PREDMETH trial published in NEJM in 2025. Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, Koopman B, Loth DW, Nossent EJ, Wagenaar M, Kramer H, Wielders PLML, Bonta PI, Walen S, Bogaarts BAHA, Kerstens R, Overgaauw M, Veltkamp M, Wijsenbeek MS; PREDMETH Collaborators. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate. N Engl J Med. 2025 Jul 17;393(3):231-242. doi: 10.1056/NEJMoa2501443. Epub 2025 May 18. PMID: 40387020. https://www.nejm.org/doi/full/10.1056/NEJMoa2501443 Meet Our Hosts Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a first year pulmonary and critical care fellow at Johns Hopkins. Key Learning Points Clinical context Prednisone remains the traditional first-line treatment for pulmonary sarcoidosis when treatment is indicated, with evidence for short-term improvements in symptoms, radiographic findings, and pulmonary function—but with substantial, familiar steroid toxicities (weight gain, insomnia, HTN/DM, infection risk, etc.). Despite widespread use, glucocorticoids haven't been robustly tested head-to-head against many alternatives as initial therapy, and evidence for preventing long-term decline (especially in severe disease) is limited. Immunosuppressants (like methotrexate) are often used as steroid-sparing agents, but guideline recommendations are generally conditional/low-quality evidence, and practice varies. Why PREDMETH matters It addresses a real-world question: Can methotrexate be an initial alternative to prednisone in pulmonary sarcoidosis, rather than being reserved only for steroid-sparing later? It also probes a common clinical belief: MTX has slower onset than prednisone (often assumed, not well-proven). Trial design (what to know) Open-label, randomized, noninferiority trial across 17 hospitals in the Netherlands. Included patients with pulmonary sarcoidosis who had a clear pulmonary indication to start systemic therapy (moderate/severe symptoms plus objective risk features like reduced FVC/DLCO or documented decline, plus parenchymal abnormalities). Excluded: non–treatment-naïve patients and those whose primary indication was extrapulmonary disease. Treat-to-tolerability with escalation: both drugs started low and were slowly increased; switch/add-on allowed for inadequate efficacy or unacceptable side effects. Primary endpoint: change in FVC (with the usual caveat that FVC is “objective-ish,” but effort-dependent and not always patient-centered). Noninferiority margin: 5% FVC, justified as within biologic/measurement variation and “not clinically relevant.” Outcomes assessed at weeks 4, 16, 24; powered for ~110 patients to detect the NI margin. Patient population (who this applies to) Mostly middle-aged (~40s) with mild-to-moderate physiologic impairment on average (FVC ~77% predicted; DLCO ~70% predicted). Netherlands-based cohort with limited Black representation (~7%), which matters for generalizability. Would have been helpful to know more about comorbidities (e.g., diabetes), which can strongly influence prednisone risk. Main findings (what happened) Methotrexate was noninferior to prednisone at week 24 for FVC: Between-group difference in least-squares mean change at week 24: −1.17 percentage points (favoring prednisone) with CI −4.27 to +1.93, staying within the 5% NI margin. Timing mattered: Prednisone showed earlier benefit (notably by week 4) in FVC and across quality-of-life measures. By week 24, those early differences largely washed out—possibly because MTX “catches up,” and/or because crossover increased over time. In their reporting, MTX didn't meet noninferiority for FVC until week 24, supporting the practical message that prednisone works faster. Crossover and analysis nuance (important for interpretation) Crossover was fairly high, which complicates noninferiority interpretation: MTX arm: some switched to prednisone for adverse events and others had prednisone added for disease progression/persistent symptoms. Prednisone arm: some had MTX added. In noninferiority trials, heavy crossover can bias intention-to-treat analyses toward finding “no difference” (making noninferiority easier to claim). Per-protocol analyses avoid some of that but introduce other biases. They reported both. Safety signals (what to remember clinically) Adverse events were very common in both arms (almost everyone), mostly mild. Side-effect patterns fit expectations: Prednisone: more insomnia (and classic steroid issues). MTX: more headache/cough/rash, and notably liver enzyme elevations (about 1 in 4), with a small number discontinuing. Serious adverse events were rare; numbers were too small to confidently separate “signal vs noise,” but overall known risk profiles apply. Limitations (why you shouldn't over-read it) Open-label design, and FVC—while objective-ish—is still effort-dependent and can be influenced by expectation/behavior. Small trial, limiting subgroup conclusions (e.g., severity strata, different phenotypes). Generalizability issues (Netherlands demographics; US populations have higher rates of obesity/metabolic syndrome, which may tilt the steroid risk-benefit equation). Crossover reduces precision and interpretability of between-group differences over time. Practice implications (the “so what”) For many patients with pulmonary sarcoidosis needing systemic therapy, MTX is a reasonable initial alternative to prednisone when thinking long-term tolerability and steroid avoidance. Prednisone likely provides faster symptom/QoL relief in the first weeks—so it may be preferable when rapid improvement is important. The trial strengthens the case for a patient-centered discussion: short-term relief vs side-effect tradeoffs, and the possibility of early combination therapy in more severe cases (suggested, not proven).

Healthcare does not lack workers; it lacks a work model capable of supporting them. Modern care assumed infinite elasticity from clinicians, but that model has reached its limit. What comes next is not incremental change; it is reconfiguration: team-based, patient-centered, digitally enabled, and economically aligned with value. When the work is redesigned, the workforce stabilizes. This necessary reconfiguration is not a trend; it is an inescapable reality.

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics:  Overview: Molecular basis of antibody-drug conjugate (ADC) toxicities — Sequencing of ADCs and mechanisms of resistance (0:00) Case: A woman in her late 60s with localized triple-negative breast cancer develops myocarditis during neoadjuvant therapy with chemotherapy/pembrolizumab — Richard Zelkowitz, MD (8:22) Case: A woman in her mid 70s with recurrent ER-negative, HER2-low, PD-L1-positive metastatic breast cancer (mBC) who experiences disease progression on nab paclitaxel/atezolizumab responds to sacituzumab govitecan — Ranju Gupta, MD (26:43) Case: A woman in her early 80s with recurrent ER-positive, HER2-low (IHC 1+) mBC experiences disease progression on trastuzumab deruxtecan (T-DXd), then receives datopotamab deruxtecan and develops pulmonary symptoms — Laila Agrawal, MD (32:11) Data Review: T-DXd (37:51) Case: A woman in her early 70s with recurrent ER-positive, HER2-low (IHC 1+) mBC, including bladder metastases, experiences disease progression after palbociclib/letrozole, then capivasertib/fulvestrant, then nab paclitaxel — Justin Favaro, MD, PhD (44:02) Case: A woman in her late 70s with ER-positive, HER2-low mBC who experiences disease progression after 1 year of ribociclib/letrozole receives sacituzumab govitecan — Erik Rupard, MD (55:19) CME information and select publications

If you've struggled with weight loss despite clean eating, exercise, or fasting and you have a thyroid hormone imbalance or no thyroid at all—this episode is for you. In this episode, Dr. Rebecca Warren shares why weight loss resistance is so common with thyroid conditions and why doing more isn't always the answer. She walks through four essential steps that must be addressed to support metabolism and hormone balance, especially for those with hypothyroidism, Hashimoto's, or living post-thyroidectomy. This episode is about understanding why the body resists weight loss—and what needs to be in place before it can change.

Aerial photographs, weather observation and even food delivery are a few of the uses for drones. What about getting emergency medical equipment to rural areas where it’s needed, quickly? There’s now a public-private partnership aiming to use drones to do just that in central Pennsylvania. The U-S Department of Justice says it won’t require names of minors who received gender-affirming care at hospitals operated by UPMC. Patients' identities are embedded into their medical files. The holiday travel season is expected to set records. AAA estimates more than 122 million Americans will travel at least 50 miles from home between December 20th and January 1st. Pennsylvania Attorney General Dave Sunday is now serving in a leadership role among Eastern U-S attorneys general. More than 14-million dollars in grant funding is being awarded to community projects across Pennsylvania, by the state's Department of Community and Economic Development. The projects support communities in four areas: flood mitigation, recreational trails, improvements to sewage facilities and watersheds. More than 4.4 million dollars is being awarded to about 30 community projects in Dauphin County. If you're already a member of WITF's Sustaining Circle, you know how convenient it is to support programs like the Morning Agenda. By increasing your monthly gift, you can help WITF close the budget gap left by the loss of federal funding. Visit us online at witf.org/increase or become a new Sustaining Circle member at www.witf.org/givenow. Thank you.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

What if your marketing didn't require constant posting or starting from scratch every week, and could take up a lot less time for a lot more payoff? In this episode, I'm joined by Jana Osofsky (also known as Jana O), marketing strategist for wellness practitioners and creator of the Blog First marketing ecosystem.We talk about writing content that meets people where they are, avoiding jargon that turns patients away, and using blogs as the foundation for everything from emails to social posts. Jana also explains how to use AI thoughtfully without losing your voice, why specificity matters more than niching down, and how to create marketing that feels spacious, aligned, and effective without burning out.What You'll Learn:How to turn one blog into a full month of marketing content.How to write in a way that attracts patients in a way that makes sense to them and you.How to use AI as a support tool–not your marketing strategist–to amplify your voice, leverage SEO and increase your credibility.Timestamps: 2:49 - Meet Jana Osofsky6:31 - Jana's business beginnings & entering her repurposing era11:24 - SEO, marketing, and your blog18:17 - How to write for your audience20:01 - Acupuncturist example: moving through buyer awareness25:47 - Do you really need to niche down?32:07 - Why topic selection goes first before creating content34:54 - How to use AI for your marketing content42:22 - Jana's definition of successMentioned in this episode:Eugene Schwartz's Book: breakthroughadvertisingbook.comConnect with Jana:Website: janaomedia.comFree Blog Training: janaomedia.com/free-blog-trainingMichelle's Retreat: michellegrasek.com/planning-retreat

Send us a textTheOncoPT Podcast officially turned SEVEN, y'all! And a beautiful part of being around this long means that it's time for some knowledge updates:Bone Marrow Transplant (BMT) and CAR T-cell therapy are evolving fast—are you keeping up? In this episode of TheOncoPT Podcast, Dr. Adam Matichak returns to share the latest updates on these groundbreaking treatments and what they mean for your OncoPT practice.You'll learn how CAR T-cell therapy is expanding, why mobility strategies matter more than ever, and how to use vital signs to guide your treatment decisions. Plus, we'll explore how you can advocate for rehab's role in oncology, prepare patients for complex treatments like BMT and CAR T, and find the resources you need to stay ahead in this rapidly changing field.Whether you're new to cancer rehab or a seasoned pro, this conversation will give you practical tools to treat your patients undergoing BMT and/or CAR T-cell therapy. Listen now!Follow TheOncoPT on Instagram.Follow TheOncoPT on LinkedIn.

In episode 64 of Going anti-Viral, we look back at the past year and beyond to share highlights from past episodes of the Going anti-Viral Podcast. In this selection of highlights, we share the remarkable outcomes of scientific research, hearing from researchers, clinicians, and survivors. These outcomes are the result of the tremendous work and innovation of our guests and the entire scientific research community and the investment of the American people in scientific research. 0:00 – Introduction 1:29 – Dr Judith Currier – Next-Gen HIV Prevention and Treatment 1:59 – Dr Anthony Fauci – A Conversation with Dr Anthony Fauci 2:33 – Dawn Averitt – A Personal Journey with HIV and Advocacy for HIV Research 3:18 – Rebecca Denison – 40+ Years of HIV: What's Changed, What Hasn't, What Shouldn't, What Must 3:44 – Dr Izukanji Sikazwe – Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind 4:19 – Dr Joseph Eron – HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025 4:48 – Dr Diane Havlir – Preview of the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) 5:22 – Dr Peter Hotez – The Measles Outbreak and the Role Anti-Science Plays in Threatening Public Health 5:58 – Dr Steven Grinspoon – The Management of Cardiovascular Health in Patients with HIV 6:18 – Dr Ellen Eaton – Treating Substance Use Disorder in an Inpatient Setting 6:41 – Dr Khalil Ghanem – Demystifying Syphilis: Diagnosis and Treatment 7:01 – Dr Carlos del Rio – Providing Healthcare to Foreign-Born and Hard-to-Reach Individuals 7:37 – Dr Yvonne Maldonado – How Vaccines Get Approved in the US: The RSV Story and the Role of the ACIP 8:00 – Dr Demetre Daskalakis – The CDC without Scientific Leadership 8:29 – Dr Rochelle Walensky – The COVID-19 Pandemic and the Current State of Public Health in the US 9:01 – Mary Fisher – Breaking the Silence: An Activist's ApproachFor full episodes, visit the Going anti-Viral Podcast on Spotify and Apple Podcasts__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Small Changes that Make A Big Impact As podiatrists, we're often guilty of letting the week run us, rather than intentionally designing our schedules to work for us. Patients pile in, admin creeps into every gap, and before we know it, another week (or year) has flown by in a blur. In this solo episode, I discuss why so many podiatry business owners feel overworked and scattered, and how a few small changes can transform your weekly rhythm, energy, and impact. The main culprits behind a chaotic week? Overcommitment – Saying yes to everything, leaving no time to breathe Lack of boundaries – Letting patients, staff, or admin tasks blur personal time Energy mismatches – Doing low-value work when you're mentally at your best The good news? You don't need a total overhaul. Just a few small tweaks. For more detailed notes, please visit www.podiatrylegends.com/blog No one wants a business coach; however, if you are looking, let's talk.   A business owner I spoke with in early 2024 made an extra $40,000 by following my advice from a 30-minute FREE Zoom call. They were so happy that they bought me a $400 bottle of bourbon. That's a win-win for both of us. Think about it - You have everything to gain and nothing to lose. Please use the link below to schedule your Zoom call.  https://calendly.com/tysonfranklin/podmeeting30  If you're not yet ready to contact me, consider buying my Books - https://amzn.to/4oBl3r3

Dr Lisa A Carey from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Rita Nanda from The University of Chicago in Illinois engage in an evidence-based discussion around real-world cases involving common toxicities associated with antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

Summary In this truncated replay from the 2025 SF Derm Annual Conference, Dr. David Cotter discusses the implications of latent tuberculosis in dermatology, particularly in psoriasis treatment. He highlights the prevalence of latent TB, risk factors, and the importance of targeted screening. This session also addresses the mental health challenges faced by psoriasis patients and evaluates the safety of new treatments, emphasizing the need for careful monitoring and patient support. Takeaways - The prevalence of latent TB infection in the U.S. is 5%. - Healthcare workers have a higher risk of latent TB. - Patients on TNF inhibitors are significantly more likely to develop active TB. - Screening for latent TB should be targeted to high-risk patients. - Annual TB screening is not necessary for most psoriasis patients on IL-17 and IL-23 inhibitors. - The cost of screening for latent TB can be substantial. - Patients with psoriasis have higher rates of suicidal ideation and behavior. - Effective psoriasis treatment can improve mental health outcomes. - The event rate for suicide in clinical trials is very low. - Monitoring for mental health issues is crucial in psoriasis treatment. Chapters 00:00 - Understanding Latent Tuberculosis in Dermatology 08:40 - Mental Health and Psoriasis: A Critical Connection

Can patient care be improved by including nutritional counselling? Dr. Mina Fahmy is an Oral Maxillofacial surgeon practicing in Washington State, and his dual background in medical nutrition and surgery informs his approach to patient care. During this episode, he shares how this combination of expertise shapes his pre-op consultations, and optimizes both clinical outcomes and patient well-being. We talk about protein, hydration and other key diet factors that support the body's healing. We also discuss where Dr. Fahmy sees nutrition fitting into patient care in the future and touch on the social media channel he is building to educate and empower patients and surgeons. You'll also hear one power tip from a recent inspiring book that Dr. Fahmy read, learn what motivates him outside the workplace, and more. Thanks for listening! Key Points From This Episode:How Dr. Fahmy's background in medical nutrition as well as surgery shaped his approach to patient care.Pre-op nutrition and health markers that Dr. Fahmy prioritizes. Understanding the holistic nature of nutrition. Supporting elderly patients with bone and immune issues.Supplements for immune and inflammation support.Post-op recommendations for different categories of patients. The key role of hydration in healing.Incorporating nutrition counselling into consultation.Starting small and being consistent in order to create a lasting impact. Where Dr. Fahmy sees nutrition fitting into patient care in the future. A power tip that he lives by. Links Mentioned in Today's Episode:Dr. Mina Fahmy — https://advanceddios.com/about/meet-mina-fahmy/ Dr. Mina Fahmy Email — minadfahmy@gmail.com Outlive — https://www.amazon.com/Outlive-Longevity-Peter-Attia-MD/dp/0593236599/ref=sr_1_1 Save That Face on Instagram — https://www.instagram.com/savethatface/ Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

Happy Holidays! With time off (hopefully) in the not-so-distant future, it is important that your patients AND team are prepared for any holiday closure time. Patients should ideally be made aware of any practice closures in advance. Emails, texts, or custom recorded voicemails are the best way to ensure that patients know you are closed AND know what to do if they have a dental emergency. Your team also needs to know the expectations for checking email, voicemail, and text messages while the practice is closed. Listen in to these reminders to ensure that you are fully prepared for any time off this week! 

Featuring perspectives from Dr Yelena Y Janjigian, including the following topics: Introduction (0:00) Case: A man in his early 60s with a history of Barrett's esophagus presents with HER2-positive metastatic esophageal adenocarcinoma and a PD-L1 combined positive score (CPS) of 3 — Jennifer Yannucci, MD (10:20) Case: A man in his early 60s with multiregimen-recurrent HER2-positive gastroesophageal junction (GEJ) adenocarcinoma (claudin 18.2-positive, PD-L1 CPS 0) — Neil Morganstein, MD (14:53) Case: A woman in her early 80s with dementia and newly diagnosed mismatch repair-deficient, PD-L1-positive metastatic GEJ adenocarcinoma — Brian P Mulherin, MD (25:55) Case: A man in his mid 60s with localized HER2-negative GEJ cancer (PD-L1 CPS 2, claudin 18.2-positive) and residual disease after receiving neoadjuvant chemoradiation therapy and undergoing surgery — Stephen "Fred" Divers, MD (32:18) Case: A man in his early 80s with metastatic recurrence of esophageal adenocarcinoma and a PD-L1 total proportion score of 75% 2 years after resection of localized disease — Susmitha Apuri, MD (40:28) Case: A man in his mid 70s with claudin 18.2-positive metastatic esophageal adenocarcinoma who develops progressive toxicities with FOLFOX and zolbetuximab — Sean Warsch, MD (52:54) CME information and select publications

Dave Sather is a Certified Financial Planner and founder/CEO of Sather Financial Group, a $2 billion fee-only investment management firm in Victoria, Texas, who has built authentic client relationships through disciplined value investing over 25+ years while creating the award-winning Bulldog Investment Company student internship program at Texas Lutheran University.Episode Sponsor: Fiscal AI is a modern data terminal that gives investors instant access to twenty years of financials, earnings transcripts, and extensive segment and KPI data—use my link for a two-week free trial plus 15% off: https://fiscal.ai/talkingbillions/3:00 - Dave shares formative childhood shaped by Depression-era parents who instilled frugality, work ethic, and educational investment. Required to save 50% of all earnings for college from early age, working multiple jobs at 14 to fund goals.6:30 - Career path story: From El Paso military town to Texas Lutheran education, initially resisting Victoria, Texas but relocating for family obligations. Started advisory firm during 1990s Texas recession when banks and real estate were collapsing.9:00 - Building relationships in small-town Victoria became competitive advantage. “If I do the right thing by my clients, word of mouth is going to take care of me.” Community connections and authentic service created organic growth without marketing spend.15:00 - Philosophy shift from finding cheap investments to recognizing exceptional value. “I can pay a premium for really good stuff that can grow for a long time versus buying things that are just cheap.”27:00 - The Bulldog Investment Company program: Student-run fund managing real money, teaching ownership and accountability. Students present investment cases, debate merits, vote democratically on portfolio decisions.42:00 - Client relationship insights: Treating wealth transitions with care, understanding accumulation psychology. “This client didn't just wake up one day with five million dollars and decide to behave like an idiot.”54:00 - Success definition: Access to basics (water, food, healthcare, safety), meaningful work, strong marriage, 40-year friendships that pass the “2 a.m. test” - relationships where you'd help immediately without excuses.Podcast Program – Disclosure StatementBlue Infinitas Capital, LLC is a registered investment adviser and the opinions expressed by the Firm's employees and podcast guests on this show are their own and do not reflect the opinions of Blue Infinitas Capital, LLC. All statements and opinions expressed are based upon information considered reliable although it should not be relied upon as such. Any statements or opinions are subject to change without notice.Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed.

In this episode, Dipak Kalra, President of the European Institute for Innovation through Health Data, joins Faces of Digital Health to break down the real progress (and real gaps) in European health data, from legacy “hybrid” paper/digital workflows to the underused potential of clinical decision support that depends on structured data. We explore what EHDS changes—especially the promise of a standardized, downloadable patient dataset—and what it could unlock for patient-facing apps, analytics, and more active self-management. We also tackle the hard questions: how to protect citizens from misuse and scams, how opt-out choices might create bias in research and AI, why “beating clinicians with a stick” won't fix data quality, and why delays aren't just bureaucratic—they can translate into avoidable harm. 02:00 The State of Healthcare Data in Europe 07:59 Challenges in Data Interoperability 12:31 The Role of Patients in Data Management 16:37 AI and Data Privacy Concerns 22:01 Patient Consent and Data Usage 28:00 Optimism for the Future of Health Data 31:03 Optimistic Futures for EAGDS 33:02 Preparing for EHDs: Readiness and Challenges 35:48 Data Quality and Workforce Challenges 37:58 Delays and Future Discussions on EHDs 39:53 The Urgency of Health Data Readiness 42:38 The Evolving Role of Patients in Healthcare 50:19 Building Trust Among Healthcare Stakeholders 57:58 The Future of Healthcare Data Discussions

In this episode of the GrowDental podcast, Luke dives into the r/Dentistry subreddit to answer real questions from practice owners struggling with marketing and growth. What emerged from those conversations is a framework that challenges everything most dentists believe about their biggest constraint. Get your copy of the Practice Paradox and the Personality Assessment: https://ion.agency/practice-paradox-book A dentist buys a South Florida practice. Previous spend: $5,000 monthly on ads. New plan: hire a strategist, reorganize, cut costs. Result: phones go silent, patient flow crashes. The owner’s instinct? Panic. The real question: Was $5k the problem? Here’s what actually happened. Spend less, get less. That part is simple math. The complicated part lives downstream. What happens after someone calls or fills out a form? Because in most practices, the enemy isn’t your marketing budget. It’s operational leakage. Missed calls. Weak follow-up. Zero visibility into what your website produces. If that’s your reality, more ad spend won’t solve growth. It will scale your waste. This framework is for owners who want to grow the right way. Plug the leaks first. Scale what works second. The Trap — Treating Marketing Like the Problem When It’s Just the Amplifier Most budget arguments skip the only question that matters. Are you stewarding the opportunities you already pay for? Marketing is not magic. Marketing is volume. Turn it up and you get more attention, more inquiries, more exposure of whatever’s broken underneath. In the South Florida case, the most predictable outcome occurred. They cut spend and lead flow dropped. That doesn’t prove the original budget was right or efficient. It proves it was producing volume. But the real insight is this: ad spend is relative. Consider the context. Where exactly are you? Miami versus a suburban market are different games. How competitive is your local area? How big is the practice now, and how fast do you want to grow? A flat number like $5,000 monthly means nothing without those answers. In some markets it’s average. In others it’s conservative. In others it’s reckless. But even if your spend level fits your market, your biggest constraint may still be operational, not marketing. Free Growth Session The Silent ROI Killer — Missed Calls and Abandoned Calls Want one metric that exposes the truth fast? How many calls are you missing right now? Not what your team thinks. Not what feels right. The hard number. Here’s the reality most owners avoid. The average abandoned call rate sits between 20 percent and 40 percent of calls going unanswered. Pause on that. If you miss one out of four calls, you don’t have a lead generation problem. You have a conversion capture problem. And if a meaningful chunk of those missed calls are new patients, you’re bleeding revenue daily without knowing it. Why This Matters More Than Your Ad Budget The compounding effect looks like this. Your missed call rate is 25 percent today. You crank marketing spend up. You push your team beyond capacity and that missed call rate climbs to 40 percent or higher. So you spend more. You get more inquiries. You lose more opportunities because your systems can’t absorb the volume. This is how practices convince themselves marketing doesn’t work, when the truth is they never fixed the bucket. Where to Find the Truth (Not Opinions) Most practices already have the data. Owners just don’t look. You likely use a VoIP system. Those platforms show call stats, including abandoned call rate and missed calls. The next step isn’t just the percentage. It’s segmentation. What percentage of missed calls are new patient calls? That one metric tells you whether your next dollar goes to ads or operations. The Other Black Hole — “How Many New Patients Did Your Website Bring You?” One strategist asks a question almost nobody can answer. “In 2025, how many new patients did your website bring you?” Common response: silence. This isn’t a minor gap. It’s a fundamental business blind spot. If you can’t measure what the website produces, you can’t evaluate whether your site does its job, whether your online scheduling gets used, whether your forms get answered, or whether you’re losing patients quietly while telling yourself the website is decent. The Website Isn’t Just Branding Sure, a website informs people. But in the context of practice growth, it has a job. Turn interest into action. If you don’t know whether it’s doing that, you’re operating on vibes. The Practical Audit Most Practices Never Do If your lead flow feels low, take a hard look at where you’re bleeding. Start with two questions. What are the form submissions and appointment requests like? Where are those requests being routed, and who owns follow-up? Because “we don’t get website leads” is sometimes code for something else. Requests go into an inbox nobody monitors. Notifications go to the wrong person. Patients get a slow response and ghost. The follow-up experience feels cold and transactional. In other words, the website might be working. Your process might not. Free Growth Session Google vs. Meta Isn’t a Preference Debate. It’s an Intent and Workflow Debate. A lot of dentists talk about Google versus Facebook like it’s personal preference. It’s not. It’s about patient intent and what your practice can handle. Here’s the breakdown. Google is more bottom-of-funnel because you capture existing search intent. People actively looking. But it’s also more competitive, and demand is limited by how many people search in your area. Meta (Facebook and Instagram) is more top-of-funnel. You reach people who could become patients, but you often need workflows and automations to warm them up and convert them. Here’s the operational reality most practices miss. If your follow-up is weak, top-of-funnel leads die. If your phones aren’t answered consistently, bottom-of-funnel leads die too. The platform won’t save you from poor stewardship. This is why fixing leaks first is so powerful. It makes every channel work better. The “Plug the Leaks” Growth Framework — What to Fix Before You Spend More If your schedule isn’t where you want it, your instinct may be to throw money at marketing. Sometimes that’s right, but only after you validate the fundamentals. Here’s a practical sequence. Step One — Pull Your Phone Data Today Log into your VoIP system. Find your abandoned call rate and missed calls. Identify what percentage of missed calls are likely new patients. If you’re missing a big chunk of calls, that’s not a marketing problem. That’s an operations problem that marketing will only magnify. Step Two — Review the Follow-Up Experience (Not the Theory) A simple but revealing approach: listen to phone calls and evaluate customer service like a real consumer would. If you want to remove self-deception, do what one doctor did. Call your own practice pretending to be a patient to screen the phone experience. This isn’t about being sneaky. It’s about being honest. Owners often assume the experience is good because the team is nice. But nice doesn’t always mean confident, efficient, or conversion-minded. Step Three — Audit Your Website Conversion Path End-to-End Don’t argue about whether the site looks good. Ask how many appointment requests come in. Are submissions truly zero, or just disappearing? Who is responsible for responding, and how fast? If you discover leads are coming in but not getting handled well, the fix might be far cheaper than increasing ad spend. Step Four — Only After the Leaks Are Plugged, Decide Whether to Scale Spend At that point, scaling marketing becomes rational because you’re scaling a machine that can actually capture demand. A practical benchmark: marketing spend often falls around 5 percent to 12 percent of collections. Don’t treat that as a rule. Treat it as a reality check and tie your decision back to your market competitiveness, your growth goals, and your operational readiness to handle more volume. One more sharp point: if you truly want to grow aggressively, you may need to think in terms of the percentage of where you want to be, not just where you are. That can work, but only if you’ve already fixed the conversion bottlenecks. Free Growth Session When the Answer Really Is “Spend More” (And How to Do It Without Getting Burned) Sometimes, after you do the audits above, you’ll confirm something important. Call volume is genuinely low. Website requests are genuinely low. You’re not leaking opportunities. You simply don’t have enough opportunities. In that case, the advice is direct. You just need to spend more. But even then, don’t blindly hire anyone who sells ads. Use a vetting process that protects you from expensive mistakes. Find a reputable marketing company with case studies and testimonials from doctors you’d actually want to emulate. Ask to speak with three to five of those doctors. Do real research, then make an educated decision. That last part matters. Dentists often buy marketing like they buy equipment, based on features. But marketing is closer to hiring. You’re paying for execution quality, strategy alignment, and consistency. The Bottom Line — Marketing Isn’t Your Growth Strategy. Stewardship Is. If you remember one thing from this entire framework, make it this. Marketing doesn’t fix a leaky practice. Marketing exposes it. If your phones go unanswered, if your follow-up is inconsistent, if you don’t know what your website produces, then scaling marketing is like pouring water into a bucket with holes. You’ll feel busy, spend more, and still wonder why the finances don’t add up. But if you plug those holes, if you maximize stewardship, then marketing becomes what it’s supposed to be. A predictable lever you can pull to grow. The owner in the South Florida story didn’t discover that marketing is bad. They discovered something more useful: their spend was driving demand, and the moment they removed it, demand dropped. The correct response isn’t to argue about whether $5k is too much. The correct response is to build a system that can reliably convert whatever demand you create, then scale with confidence. Free Growth Session The post Your Dental Practice Is Bleeding Patients (And Marketing Isn’t the Problem) appeared first on HIP Creative.

We're continuing our holiday break from regularly scheduled programming to bring you another foundational resource: the patient communication strategies that transform ketamine therapy from a clinical procedure into a truly healing experience.This episode originally came from one of our mastermind sessions with students from our Ketamine Startup 101 course, where we dove deep into patient preparation and emotional safety protocols. It's become one of our most popular episodes..Whether you're building a ketamine practice, looking to elevate your current patient communication, or trying to understand what separates exceptional clinics from those that simply provide treatment, this episode gives you the complete framework. This is part of our "Episodes from the Vault" series, bringing back content that continues to serve as the go-to resource for healthcare providers focused on patient experience excellence. For those who may recall, this was originally released as Episode 33. The mastermind format allowed us to go deep on each communication strategy while keeping everything immediately actionable for real-world implementation.This episode is especially valuable if you're training staff members, standardizing patient communication protocols, or seeking to create the kind of trust and safety that enables true therapeutic transformation. The strategies we share bridge clinical excellence with emotional intelligence which is exactly what ketamine therapy demands.What You'll Learn in This Episode • The four essential communications every ketamine patient needs before treatment• Specific language and techniques for normalizing anxiety and fostering trust• How to prepare patients for non-ordinary experiences while ensuring emotional safetyEpisode 47 show notes:00:00 Teaser - Why presence matters00:49 Episode introduction 01:59 The Patient Communication Framework - The four essential things patients need to know and why therapeutic experience begins before treatment06:14 #1: Feeling Nervous is Normal - Acknowledging patient anxiety, pre-framing concepts, and diving board metaphor for first treatments10:59 #2: They May See, Feel, or Realize Big Things - Preparing patients for non-ordinary states of consciousness and ensuring they understand experiences will end15:08 #3: Physical Sensations May Happen - Managing nausea, dizziness, and physical side effects with proactive medical interventions17:31 #4: Emotional Releases Are Possible - Creating safe space for tears, anger, and grief while normalizing emotional expression27:31 Practical Implementation Tips - Team training strategies, consistent language protocols, and creating emotionally safe clinical environments30:19 Episode wrap-upSelected Links From the Episode: This book link in these show notes is an Amazon affiliate link. If you purchase through these links, we may earn a small commission at no additional cost to you.

Renato (Ren) Circi, co-founder of SAVA, a London based MedTech company building a new generation of minimally invasive continuous glucose monitors and molecular wearables.In this episode we rewind to the underground labs at Imperial College London where Ren and his co-founder Raph first immersed themselves in biosensors and began questioning the status quo of health monitoring. Ren explains how their shared obsession with measuring the body more effortlessly led to SAVA's founding and what it really looks like to push through years of scientific failure in order to build a complex medical device platform.We dive into why SAVA manufactures everything in-house, how their micro sensor architecture differs from traditional filament based CGMs and why controlling every layer from chemistry to algorithms is essential if you want to iterate fast on performance. Ren sets out SAVA's long term vision of continuous molecular tracking for everyone, not just people with diabetes, and what could be unlocked once you can monitor many molecules in real time from a single patch.We also talk about regulatory expectations for CGMs, the reality of one way product decisions in medical devices and the difficulty of fundraising for a consumer facing yet highly regulated deep tech company. Ren closes with candid reflections on what he would do differently, how he protects time for family and why working on a problem you truly care about with people you genuinely like is the only way to survive the journey.Timestamps[00:00:21] Origins at Imperial and discovering biosensors[00:01:59] Long horizons, repeated failure and staying in the game[00:03:56] Why SAVA manufactures everything in-house[00:06:46] How SAVA's micro sensor CGM platform actually works[00:09:36] From diabetes to universal molecular health monitoring[00:12:02] Patient experience and CGM adoption in healthcare systems[00:13:43] When CGMs become cheaper than finger-pricks[00:15:15] Misconceptions about CGM and continuous molecular sensing[00:17:21] Why building CGMs is one of the hardest engineering challenges[00:22:54] Fundraising in unconventional deep tech MedTech and advice for foundersConnect with Ren - ⁠⁠https://www.linkedin.com/in/circi/⁠Learn more about Sava - ⁠⁠https://www.sava.health/Get in touch with Karandeep Badwal - ⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠Follow Karandeep on YouTube - ⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠Subscribe to the Podcast

Mike Johnson, Beau Morgan, and Ali Mac face the good and bad picks they made on Friday in Man Up Monday, and then close out hour two by diving into the life of Mike Johnson and getting Mike'd Up!

After 30 years in emergency medicine, Dr Newman learned a hard truth: She could save patients through their crisis, but they never actually got better. They'd leave with longer medication lists, only to return sicker. It wasn't until her own health crashed during menopause that she discovered cellular medicine - the missing piece that explains why we stay sick. In this conversation with Dr. Siobhan Newman, you'll discover why your mitochondria might be "underwater," her three dietary "nos" that are silently destroying your cellular health, and the recovery-first approach that must happen before any optimization. We dive deep into the inflammatory cascade, why COVID taught us so much about immune dysfunction, and practical steps you can take today to support true healing at the cellular level. If you're tired of managing symptoms instead of addressing root causes, this episode will change everything. For the complete show notes, links and transcripts, visit inspiredliving.show/223

In this episode of Dr. Marianne-Land, I speak with fat activist, TEDx speaker, author, DEI expert, and podcast host Vinny Welsby (they/them) about anti-fat bias in healthcare, weight stigma in medicine, and the real-world harm fat patients experience when seeking medical care. Vinny, who shares extensively about fat liberation, weight-inclusive care, and dismantling diet culture on Instagram at @fierce.fatty, brings both lived experience and data into this conversation. This episode centers on Vinny's survey of 270 fat people, in which 99.25% reported experiencing weight-based discrimination in healthcare. These findings expose how common medical weight stigma, anti-fatness, and provider bias truly are, and why so many fat people delay or avoid healthcare altogether. Weight Stigma in Healthcare: Survey Data and Lived Experience We break down what those survey results actually mean for patients. Vinny shares stories of medical dismissal, misdiagnosis, delayed treatment, and humiliation in healthcare settings, including being told to lose weight instead of receiving appropriate medical evaluation. We discuss how weight stigma shows up through provider assumptions, lack of size-inclusive equipment, routine weighing without consent, and dismissive or dehumanizing language. This section highlights how anti-fat bias in healthcare leads to worse physical health outcomes, increased medical trauma, and deep mistrust of medical systems. Medical Trauma, Nervous System Effects, and Avoiding Care We explore how repeated experiences of weight stigma activate the nervous system and create medical trauma. Even scheduling an appointment can trigger fear, shame, and exhaustion. Vinny and I talk about how this chronic stress contributes to people avoiding preventive care, delaying diagnosis, and experiencing worsening health conditions as a result. This conversation connects anti-fat bias, mental health, eating disorders, and healthcare avoidance, naming how the system often blames fat bodies for the very harm it causes. Intersectionality: Fatness, Gender, Queerness, and Neurodivergence A major focus of this episode is intersectionality. Vinny shares how anti-fatness intersected with being trans, nonbinary, queer, neurodivergent, and disabled, and how shame around body size limited access to identity exploration and self-expression. We talk about how weight stigma compounds oppression, especially for people with multiple marginalized identities. We also discuss how white privilege can reduce some harms while never eliminating weight-based discrimination, and why weight-inclusive healthcare must address racism, transphobia, ableism, and fatphobia together. What Weight-Inclusive Healthcare Actually Requires We challenge the idea that good intentions equal good care. This section explores what weight-inclusive healthcare truly requires, including provider education, consent-based weighing, size-inclusive furniture and equipment, respectful language, and accountability when harm occurs. We discuss why many providers believe they are weight-inclusive while continuing to practice weight-centered and stigmatizing care. Unlearning Anti-Fatness, Shame, and Diet Culture We close with guidance for beginning the process of unlearning anti-fatness. Vinny shares how shame thrives in isolation and how bringing it into the light reduces its power. We discuss diet culture, binary thinking, and how critical thinking helps people question harmful beliefs about weight, health, morality, and worth. This episode invites listeners to ask who benefits when people are taught to hate their bodies, and how compassion, curiosity, and community support healing. Who This Episode Is For This episode is for fat people, eating disorder survivors, clinicians, healthcare providers, and anyone who wants to understand how weight stigma in healthcare causes harm and what needs to change. About My Guest: Vinny Welsby (They/Them) Vinny Welsby is a fat activist, DEI leader, TEDx speaker, bestselling author of Fierce Fatty, and host of the Fierce Fatty Podcast. They work with individuals through Fierce Fatty and with organizations through Weight Inclusive Consulting, providing education and training on dismantling anti-fat bias in healthcare and beyond. You can find Vinny at fiercefatty.com and on Instagram at @fierce.fatty. Related Episodes When Doctors Harm: Medical Weight Stigma & Eating Disorders on Apple & Spotify. Having Anorexia in a Larger Body: Navigating Medical Anti-Fat Bias & Lack of Care with Sharon Maxwell @heysharonmaxwell on Apple & Spotify. Content Caution This episode includes discussion of medical trauma, weight stigma, eating disorders, healthcare discrimination, and systemic oppression. The harm described in this episode is real, widespread, and systemic.

This episode of the UCM podcast dives deep into the essential role patient education plays in growing an upper cervical practice.  It walks doctors through the entire patient journey—from the very first phone call to the consultation, exam, report of findings, and ongoing care—emphasizing how clear communication, visual tools, and consistent reinforcement dramatically improve retention, compliance, and referrals.  Listeners learn how small details in tone, body language, clarity, and visuals can transform patient understanding, build trust, and turn patients into confident advocates.  The episode also highlights UCM's resources, such as the patient education bundle, new patient email sequence, and fast results workshop, designed to simplify and elevate patient communication while strengthening a practice's brand and long-term growth.

Dr. Sarah Camargos continues her conversation on palliative in movement disorders by interviewing Mr. Victor McConvey. Together they discuss the current state of palliative care in movement disorders including current barriers, challenges, and future goals.

Aisling Kenny, our reporter at the New National Childrens Hospital

Master guideline-based, multidisciplinary care to better identify, screen, and manage chronic kidney disease (CKD) and cardio-kidney-metabolic (CKM) patients. Credit available for this activity expires: 12/22/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cardio-kidney-metabolic-collective-piecing-multidisciplinary-2025a1000zc8?ecd=bdc_podcast_libsyn_mscpedu

Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.CME information and select publications here.

Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.CME information and select publications here.

This episode of VHHA's Patients Come First podcast features features Kirkpatrick “Kapua” Conley, MHA, FACHE, Senior Vice President and Acute Care Market President for the Sentara Health Eastern Market. He joins us for a conversation about his work and professional journey, the Sentara's CARES team, and more. Send questions, comments, feedback, or guest suggestions to pcfpodcast@vhha.com or contact on X (Twitter) or Instagram using the #PatientsComeFirst hashtag.

https://wels2.blob.core.windows.net/daily-devotions/20251220dev.mp3 Listen to Devotion Be patient and stand firm, because the Lord’s coming is near. James 5:8 Be Patient ‘I can’t wait!’ That’s a common cry this time of year. Children have been adding items to their Christmas lists for weeks. Waiting another week to see what they may get seems unbearable. It’s just as hard for students to wait for the Christmas break. It’s equally difficult to wait when you are holding a ticket to visit relatives over the Christmas holiday. It doesn’t matter how long you stare at the calendar; there are no shortcuts. Waiting requires patience. The Bible acknowledges that patience isn’t a natural virtue in any of us. It’s especially true when life isn’t going right. When you are afflicted with sickness or are being mistreated, waiting for relief is just about the hardest thing to do. It would be much more natural to grumble and complain when your health is poor. When you aren’t being treated fairly, it’s much easier to lash out or criticize someone else to make them feel as lousy as you feel. So, the Bible tells you to be patient. That’s how God wants you to handle your frustrations and challenges in life. Sometimes you can’t overcome that sickness or get rid of that mistreatment. Yet you can still place your trust in God during those difficult times and wait for God to do his job. God did his biggest job when he sent Jesus to this earth on that first Christmas. Jesus took on himself all the abuse and mistreatment he never deserved. Jesus suffered for all the world’s spiritual sickness. Jesus took away the punishment for all our complaining, grumbling, and stinging criticisms of others. The results of Jesus’ work mean peace and forgiveness for believing hearts. ‘I can’t wait!’ can be your motto for the return of Jesus. You don’t have to count down the days on the calendar. You can wait with patience because Jesus brings more than presents, a brief visit, or a break from school. You can stand firm and eagerly wait for the blessings Jesus has in store for you when he comes back to take you home to heaven. Prayer: Lord Jesus, fill my life with your love and forgiveness so I can patiently endure earthly struggles while I wait for you to come back and bring me your eternal blessings. Amen. Daily Devotions is brought to you by WELS. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. All Scripture quotations, unless otherwise indicated, are taken from the Holy Bible, New International Version®, NIV®. Copyright ©1973, 1978, 1984, 2011 by Biblica, Inc. ™ Used by permission of Zondervan. All rights reserved worldwide.

12-19-25 - BR - MIX - 5x - Weight Loss Med Patients Plan To Pause Meds For Holidays - Jan/Fall 2024 - BOSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.